Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis

PURPOSE: This study aims to determine the influence of targeting araC-resistant acute myeloid leukemia by dual inhibition cyclin-dependent protein kinase (CDK9) and B-cell lymphoma-2 （Bcl-2). METHOD: The c-Myc inhibitor 10058-F4 and the CDK9 inhibitor AZD4573 were used to determine the cell cycle ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linzhang, Han, Chengwu, Yu, Xueying, Shen, Jun, Cao, Yongtong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808115/
https://www.ncbi.nlm.nih.gov/pubmed/35126914
http://dx.doi.org/10.1155/2022/2842066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808115/
https://www.ncbi.nlm.nih.gov/pubmed/35126914
http://dx.doi.org/10.1155/2022/2842066

Ejemplares similares